Compare Charles River Laboratories Intl. Inc (CRL) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs ArcelorMittal SA — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while ArcelorMittal SA trades at $74.74 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 4.2× Charles River Laboratories Intl. Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | MT | |
|---|---|---|
Market Cap | $13.46B | $55.88B |
Sector | Health | Basic Materials |
52-Week High | $282.00 | $75.35 |
52-Week Low | $145.57 | $32.44 |
Enterprise Value | $16.30B | $65.45B |
Dividend Yield | — | 0.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
